Delivery Order SPE2DB20D2104-SPE2DB25FMTMV
Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,483.76 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml), a medication used to treat cystic fibrosis. This non-set-aside, firm fixed price delivery order was awarded on November 20, 2025, with an ultimate completion date of November 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $8,168.13 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. This firm fixed price, non-set-aside delivery order was awarded on November 12, 2025, with an ultimate completion date of November 13, 2025. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $36,747.91 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampuls (2.5 ml units) with an ultimate completion date of October 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,167.20 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml units) under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a purchase order for a respiratory medication commonly used in the treatment of cystic fibrosis and is being delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. The contract was awarded on...
- The Defense Logistics Agency awarded a $7,147.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml), a pharmaceutical product used in respiratory treatment. Issued on December 19, 2025, with an ultimate completion date of December 22, 2025, this delivery order represents a routine medical supply transaction under a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,922.21 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. The contract, awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampules (2.5 mL) valued at $9,517.19 under a firm fixed price contract. The award, issued on November 20, 2025, with an ultimate completion date of November 21, 2025, represents a single delivery order for this specialty pharmaceutical product used in the treatment of cystic fibrosis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected through open...
- The Defense Logistics Agency awarded a delivery order valued at $3,919.36 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in the treatment of cystic fibrosis. The contract, which was competitively awarded without set-aside designation, was finalized on December 4, 2025, with an ultimate completion date of December 5, 2025. This delivery order represents a firm fixed price transaction and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $49,798.78 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml pharmaceutical products. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product commonly used in cystic fibrosis treatment. This non-set-aside, firm fixed-price delivery order has a ceiling value of $16,287.62 and an ultimate completion date of August 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...